VALUE LINE INC (VALU)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-16

Key Insights

  • Value Line appointed Dr. Alexander J. Swistel to its Board of Directors and Audit Committee, bringing medical and academic expertise to the company.
  • The appointment comes after the passing of previous director Mr. Alfred R. Fiore, indicating a transition in the company's board composition.
  • Dr. Swistel will receive the standard director's fee of $40,000 per year, in line with the company's existing compensation structure for board members.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.